Table 1.
Correlation between PRKRA expression and clinical characteristic.
| Characteristic | Low | High | p |
|---|---|---|---|
| n | 102 | 75 | |
| Age, n (%) | 0.212 | ||
| ≤65 | 49 (27.7%) | 44 (24.9%) | |
| >65 | 53 (29.9%) | 31 (17.5%) | |
| Gender, n (%) | 0.464 | ||
| female | 49 (27.7%) | 31 (17.5%) | |
| male | 53 (29.9%) | 44 (24.9%) | |
| TNM_pathologic_T, n (%) | 0.793 | ||
| T1 | 5 (2.9%) | 2 (1.1%) | |
| T2 | 15 (8.6%) | 9 (5.1%) | |
| T3 | 78 (44.6%) | 63 (36%) | |
| T4 | 2 (1.1%) | 1 (0.6%) | |
| TNM_pathologic_N, n (%) | 0.432 | ||
| N0 | 31 (18%) | 18 (10.5%) | |
| N1 | 68 (39.5%) | 55 (32%) | |
| TNM_pathologic_M, n (%) | 0.329 | ||
| M0 | 41 (23.2%) | 38 (21.5%) | |
| M1 | 2 (1.1%) | 2 (1.1%) | |
| MX | 59 (33.3%) | 35 (19.8%) | |
| Pathologic stage, n (%) | 0.808 | ||
| Stage I | 14 (8%) | 7 (4%) | |
| Stage II | 82 (47.1%) | 64 (36.8%) | |
| Stage III | 2 (1.1%) | 1 (0.6%) | |
| Stage IV | 2 (1.1%) | 2 (1.1%) | |
| Histological grade, n (%) | 0.002 | ||
| G1 | 26 (14.9%) | 5 (2.9%) | |
| G2 | 48 (27.4%) | 46 (26.3%) | |
| G3 | 24 (13.7%) | 24 (13.7%) | |
| G4 | 2 (1.1%) | 0 (0%) |